Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NANOVIRICIDES, INC. Director's Dealing 2011

Sep 12, 2011

34915_dirs_2011-09-12_04eee118-f894-434c-a684-db52aa2745f2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: NANOVIRICIDES, INC. (NNVC.OB)
CIK: 0001379006
Period of Report: 2011-09-06

Reporting Person: Diwan Anil (Director, President, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-09-06 Common Stock S 15000 $1.055 Disposed 7111030 Direct
2011-09-07 Common Stock S 30080 $1.07 Disposed 7080950 Direct

Footnotes

F1: Does not include 33,360,000 shares of common stock held by TheraCour Pharma, Inc., of which Anil Diwan holds voting and dispositive power.

F2: The purpose of this amendment is to amend the Form 4 filed on September 9, 2011 to correct a mathematical error in the shares owned by Anil Diwan following the transactions reported therein.